March 23, 2023
The next MMA online Physician Forum will discuss “Diversity in Clinical Trials” from 1 to 2 pm on Wednesday, March 29.
The forum will feature groups in Minnesota working to diversify clinical trials. Learn about the impact this work is having on the health of Minnesota’s marginalized communities, and what this means for health equity.
Speakers at the forum include:
Talaya Dendy, founder and CEO, On the Other Side, LLC
Tufia C. Haddad, MD, associate professor of oncology at Mayo Clinic; medical director of digital product/platform strategy; medical director for platform and digital innovation, Mayo Clinic Comprehensive Cancer Center; enterprise co-leader of platform and digital innovation in the Mayo Clinic Comprehensive Cancer Center
Andrew Snyder, director, Fairview Frontiers
Laurel Ries, MD, MMA president-elect, will serve as moderator.
Learning objectives for the forum include:
Summarize the climate of clinical trial diversity in Minnesota.
Examine the need for more diversity in clinical trials.
Recognize how diversity in clinical trials can improve care and outcomes for marginalized groups.
To register, click here.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.